2022 - A Proactive Data Standards Strategy to Maximize Biopharma R&D Assets

In the past two decades, regulators have placed increasing emphasis on submitting standardized data. In an age where investments in clinical development continue to climb, it is important to understand how an effective data standards strategy can help biopharma companies improve efficiencies, to maximize returns on the R&D investment.
The adoption of data standards for small to mid-sized biotech companies is lower due to much smaller and product-focused portfolios, where investing in implementing, building and maintaining libraries can be a costly affair. Although, the absence of data standardization typically hits companies at the end of the development journey, when clinical data has been handled by various CRO and technology partners, thus making managing, cleaning and analysis during submission stressful and resource intensive.
There is no one size fits all solution, but there is a solution for everyone. The key to success lies in aligning to long-term goals and implementing standardization in phases.
Register for this webinar to learn how a proactive data standards strategy can be crafted and effectively implemented, thus ensuring submission readiness while optimizing resources. Once standards are implemented, the options for automation are almost limitless, thus building efficiency and quality into processes.